References and Notes
<A NAME="RD27809ST-1A">1a</A>
Skotheim TA.
Reynolds JR. In
Conjugated Polymers.
Theory, Synthesis, Properties, and Characterization
3rd
ed.:
CRC Press;
Boca Raton:
2006.
Chap.
13 and 18.
<A NAME="RD27809ST-1B">1b</A>
Heinze J. In
Organic Electrochemistry
Lund H.
Hammerich O.
Marcel Dekker;
New
York:
2000.
<A NAME="RD27809ST-2">2</A>
Diaz AF.
Logan JA.
J. Electroanal. Chem.
1980,
111:
111
<A NAME="RD27809ST-3">3</A>
Diaz AF.
Kanazawa KK.
Gardini GP.
J. Chem. Soc., Chem. Commun.
1979,
635
<A NAME="RD27809ST-4">4</A>
Tourillon G.
Garnier F.
J. Electroanal. Chem.
1982,
135:
173
<A NAME="RD27809ST-5A">5a</A>
Groenendaal L.
Zotti G.
Aubert P.-H.
Waybright
SM.
Reynolds JR.
Adv.
Mater.
2003,
15:
855
<A NAME="RD27809ST-5B">5b</A>
Reeves BD.
Grenier CRG.
Argun AA.
Cirpan A.
McCarley TD.
Reynolds JR.
Macromolecules
2004,
37:
7559
<A NAME="RD27809ST-5C">5c</A>
Zotti G.
Zecchin S.
Schiavon G.
Verdelli B.
Berlin A.
Grimoldi S.
Macromol. Chem. Phys.
2004,
205:
2026
<A NAME="RD27809ST-6">6</A>
Wu PL.
Feng XJ.
Tam HL.
Wong MS.
Cheah
KW.
J. Am. Chem. Soc.
2009,
131:
886
<A NAME="RD27809ST-7A">7a</A>
Hanna NB.
Dimitrijevich SD.
Larson SB.
Robins RK.
Revankar GR.
J.
Heterocycl. Chem.
1988,
25:
1857
<A NAME="RD27809ST-7B">7b</A>
Baldwin JJ, and
Novello FC. inventors; US
Patent 3 892 762.
<A NAME="RD27809ST-8">8</A>
Kitchem JA.
Noble A.
Brandt CD.
Moubaraki B.
Murray KS.
Brooker S.
Inorg. Chem.
2008,
47:
9450
<A NAME="RD27809ST-9">9</A>
Nicolaou KC.
Bulger PG.
Sarlah D.
Angew.
Chem. Int. Ed.
2005,
44:
4442
<A NAME="RD27809ST-10A">10a</A>
de la Hoz A.
Díaz-Ortiz A.
Moreno A.
Langa F.
Eur. J.
Org. Chem.
2000,
3659
<A NAME="RD27809ST-10B">10b</A>
Microwaves
in Organic Synthesis
2nd ed.:
Loupy A.
Wiley-VCH;
Weinheim:
2006.
<A NAME="RD27809ST-10C">10c</A>
Microwave-Assisted
Organic Synthesis
Lidström P.
Tierney JP.
Blackwell
Scientific;
Oxford:
2004.
p.320
<A NAME="RD27809ST-10D">10d</A>
Kappe CO.
Stadler A.
Microwaves in Organic and Medicinal Chemistry
Wiley-VCH;
Weinheim:
2005.
<A NAME="RD27809ST-10E">10e</A>
de la Hoz A.
Díaz-Ortiz A.
Moreno A.
Chem. Soc. Rev.
2005,
34:
164
<A NAME="RD27809ST-10F">10f</A>
Bogdal D.
Loupy A.
Org. Process Res. Dev.
2008,
12:
710
<A NAME="RD27809ST-10G">10g</A>
Kappe CO.
Chem. Soc. Rev.
2008,
37:
1127
<A NAME="RD27809ST-10H">10h</A>
Polshettiear V.
Varma R.
Chem. Soc. Rev.
2008,
37:
1546
<A NAME="RD27809ST-11A">11a</A>
Lahred M.
Moberg C.
Hallberg A.
Acc. Chem. Res.
2002,
35:
717
<A NAME="RD27809ST-11B">11b</A>
Kappe CO.
Curr. Opin. Chem. Biol.
2002,
4:
314
<A NAME="RD27809ST-11C">11c</A>
Hayes BL.
Aldrichimica Acta
2004,
37:
66
<A NAME="RD27809ST-11D">11d</A>
Nilsson K.
Olofsson M.
Lahred M.
Top.
Curr. Chem.
2006,
266:
103
<A NAME="RD27809ST-11E">11e</A>
Appunnutah P.
Van der Eycken E.
Eur.
J. Org. Chem.
2008,
1133 ;
and references therein
<A NAME="RD27809ST-12A">12a</A>
Kotha S.
Lahiri K.
Kashinath D.
Tetrahedron
2002,
58:
9633 ; and references therein
<A NAME="RD27809ST-12B">12b</A>
Suenneman HW.
de Meijere A.
Angew.
Chem. Int. Ed.
2004,
43:
895
<A NAME="RD27809ST-12C">12c</A>
Kappe CO.
Dallinger D.
Nat. Rev.
Drug Discovery
2006,
5:
51 ;
and references therein
<A NAME="RD27809ST-13">13</A>
Pereyre M.
Quintard JP.
Rahm A.
Tin in Organic Synthesis
Butterworths;
London:
1987.
<A NAME="RD27809ST-14A">14a</A>
Nicolaou KC.
Sorensen EJ.
Classics in Total Synthesis
VCH;
Weinheim:
1996.
<A NAME="RD27809ST-14B">14b</A>
Nicolaou KC.
Snyder SA.
Classics in Total Synthesis II
Wiley-VCH;
Weinheim:
2003.
<A NAME="RD27809ST-15A">15a</A>
Schnürch M.
Flasik R.
Khan A.
Spina M.
Milhovilovix M.
Stannetty P.
Eur. J.
Org. Chem.
2006,
3286
<A NAME="RD27809ST-15B">15b</A>
Schöter S.
Stock C.
Bach T.
Tetrahedron
2005,
61:
2245
<A NAME="RD27809ST-15C">15c</A>
Deng J.
Wu Y.
Chen Q.
Synthesis
2005,
2730
<A NAME="RD27809ST-15D">15d</A>
Maes W.
Verstappen B.
Dehaen W.
Tetrahedron
2006,
62:
2677
<A NAME="RD27809ST-15E">15e</A>
Chuprakov S.
Chernyak N.
Dudnik A.
Gevrogyan V.
Org. Lett.
2007,
9:
2333
<A NAME="RD27809ST-15F">15f</A>
Chiong HA.
Daugulis O.
Org. Lett.
2007,
9:
1449
<A NAME="RD27809ST-15G">15g</A>
Díaz-Ortiz A.
Prieto P.
de Cózar A.
Cebrián C.
Moreno A.
de la Hoz A.
Aus.
J. Chem.
2009, in press
<A NAME="RD27809ST-15H">15h</A>
Huang J.
Macdonald SJF.
Harrity JPA.
Chem. Commun.
2009,
436
<A NAME="RD27809ST-15I">15i</A>
Huang J.
Macdonald SJF.
Cooper AWJ.
Fisher G.
Harrity JPA.
Tetrahedron Lett.
2009,
50:
5539
<A NAME="RD27809ST-16">16</A>
Olofsson K.
Kim SY.
Lahred M.
Curran DP.
Hallberg A.
J.
Org. Chem.
1999,
64:
4539
<A NAME="RD27809ST-17">17</A>
Heguaburu V.
Sá MM.
Scharpiro V.
Pandolfi E.
Tetrahedron Lett.
2008,
49:
6787
<A NAME="RD27809ST-18">18</A>
General Procedure:
A mixture of 3,5-dibromo-1-methyl-1H-1,2,4-triazole
(1; 200 mg, 0.83 mmol), stannyl derivative (2; 1.08 mmol), PdCl2(PPh3)2 (12
mg, 0.017 mmol) and LiCl (106 mg, 2.49 mmol) or CuI (15.8 mg, 0.083
mmol) was irradiated under argon in a Discover™ (CEM) focused microwave
reactor at 110 ˚C for 15 min. The crude products 3a and 4a-g were purified by flash chromatography
on silica gel (hexane-EtOAc).
5-Bromo-1-methyl-3-(thiophen-2-yl)-1
H
-1,2,4-triazole (3a): Mp 54-55 ˚C; ¹H
NMR (CDCl3): δ = 7.58 (dd, J = 3.7, 1.2
Hz, 1 H, H-3′), 7.28 (dd, J = 5.1,
1.2 Hz, 1 H, H-5′), 7.02 (dd, J = 5.1,
3.7 Hz, 1 H, H-4′), 3.84 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 159.0, 132.8, 129.7,
127.7, 126.8, 126.5, 36.5 (CH3).
3-Bromo-1-methyl-5-(thiophen-2-yl)-1
H
-1,2,4-triazole (4a):
Mp 67-68 ˚C; ¹H NMR
(CDCl3): δ = 7.54-7.62 (m, 2 H,
H-3′′, H-5′′), 7.19 (dd, J = 5.1, 3.7
Hz, 1 H, H-4′′), 4.06 (s, 3 H,
CH3); ¹³C NMR (CDCl3): δ = 151.1,
138.7, 129.4, 129.0, 128.0, 127.9, 37.4 (CH3).
3-Bromo-1-methyl-5-(1-methyl-1
H
-pyrrol-2-yl)-1
H
-1,2,4-triazole
(4b): Mp 41-42 ˚C; ¹H
NMR (CDCl3): δ = 6.74 (t, J = 1.8 Hz,
1 H, H-5′′), 6.41 (dd, J = 4.0,
1.5 Hz, 1 H, H-3′′), 6.14 (dd, J = 3.7, 2.6
Hz, 1 H, H-4′′), 4.06 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 149.9, 138.3, 126.8,
118.3, 113.1, 108.2, 37.1 (CH3), 36.0 (CH3).
5-(2,2′-Bithiophen-5-yl)-3-bromo-1-methyl-1
H
-1,2,4-triazole
(4c): Mp 152-154 ˚C; ¹H
NMR (CDCl3): δ = 7.61 (d, J = 3.9 Hz,
1 H, H-3), 7.31 (dd, J = 5.1,
1.1 Hz, 1 H, H-3′), 7.27 (dd, J = 3.8,
1.1 Hz, 1 H, H-5′), 7.20 (d, J = 3.9
Hz, 1 H, H-4), 7.05 (dd, J = 5.1,
3.8 Hz, 1 H, H-4′); ¹³C
NMR (CDCl3): δ = 150.7, 141.7, 138.7,
135.7, 129.5, 128.1, 125.9, 125.9, 125.0, 124.1, 35.5 (CH3).
3-Bromo-1-methyl-5-phenyl-1
H
-1,2,4-triazole
(4d): Mp 120-121 ˚C; ¹H
NMR (CDCl3): δ = 7.59-7.61
(m, 2 H, o-PhH), 7.44-7.46
(m, 3 H, m-PhH, p-PhH), 3.91 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 156.6, 139.1, 130.7,
129.0, 128.7, 126.7, 37.3 (CH3).
3-Bromo-1-methyl-5-(phenylethynyl)-1
H
-1,2,4-triazole (4e):
Mp 119-120 ˚C; ¹H
NMR (CDCl3): δ = 7.52-7.55
(m, 2 H, o-PhH), 7.28-7.94
(m, 3 H, m-PhH, p-PhH), 3.97 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 147.7, 140.3, 132.1, 132.0,
129.2, 128.7, 128.4, 121.7, 97.4, 89.5, 36.5 (CH3).
2-(3-Bromo-1-methyl-1
H
-1,2,4-triazol-5-yl)pyridine
(4f): Mp 78-80 ˚C; ¹H
NMR (CDCl3): δ = 8.68 (dd, J = 4.8, 1.8 Hz,
1 H, H-6), 8.20 (dd, J = 7.7,
1.1 Hz, 1 H, H-3), 7.85 (td, J = 7.7,
1.8 Hz, 1 H, H-4), 7.37 (ddd, J = 7.7,
4.8, 1.1 Hz, 1 H, H-5), 4.36 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 153.4, 148.9, 146.8,
138.3, 137.1, 124.5, 124.0, 39.3 (CH3).
2-(3-Bromo-1-methyl-1
H
-1,2,4-triazol-5-yl)pyrazine (4g): Mp 131-133 ˚C; ¹H
NMR (CDCl3): δ = 9.45 (s, 1 H, H-3),
8.67, 8.64 (2 × s, 2 H, H-5
and H-6), 4.34 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 151.1, 145.2, 154.1,
143.1, 142.5, 138.8, 39.3 (CH3).
<A NAME="RD27809ST-19">19</A>
General Procedure:
A mixture of 3,5-dibromo-1-methyl-1H-1,2,4-triazole
(1; 200 mg, 0.83 mmol), stannyl derivative (2; 2.16 mmol, 2.6 equiv), PdCl2
(PPh3)2 (24
mg, 0.033 mmol) and LiCl (106 mg, 2.49 mmol) was irradiated under argon
in a Discover™ (CEM) focused microwave reactor at 130 ˚C
for the appropriate time. The crude products 5a-c were purified by flash chromatography
on silica gel (hexane-EtOAc).
1-Methyl-3,5-di(thiophen-2-yl)-1
H
-1,2,4-triazole
(5a): Mp 107-108 ˚C; ¹H
NMR (CDCl3): δ = 7.71 (dd, J = 3.7, 1.1 Hz,
1 H, H-3′), 7,54 (dd, J = 3.7,
1.1 Hz, 1 H, H-3′′), 7.53 (dd, J = 5.1, 1.1
Hz, 1 H, H-5′′), 7.34 (dd, J = 4.8, 1.1
Hz, 1 H, H-5′), 7.18 (dd, J = 5.1,
3.7 Hz, 1 H, H-4′′), 7.10 (dd, J = 5.1, 3.7
Hz, 1 H, H-4′), 4.07 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 157.3, 150.0, 133.5,
128.9, 128.7, 128.6, 127.9, 127.6, 126.3, 126.2, 37.1 (CH3).
1-Methyl-3,5-bis(1-methyl-1
H
-pyrrol-2-yl)-1
H
-1,2,4-triazole
(5b): Mp 78-79 ˚C; ¹H
NMR (CDCl3): δ = 6.74 (t, J = 2.0 Hz,
1 H, H-5′′), 6.73 (dd, J = 2.0,
1.0 Hz, 1 H, H-5′), 6.62 (t, J = 2.0
Hz, 1 H, H-3′), 6.43 (dd, J = 4.4,
2.4 Hz, 1 H, H-3′′), 6.17 (dd, J = 4.0, 2.4
Hz, 1 H, H-4′′), 6.10 (dd, J = 3.4, 2.9
Hz, 1 H, H-4′), 3.94 (s, 3 H, CH3),
3.91 (s, 3 H, CH3), 3.85 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 155.9, 148.0, 126.1,
125.0, 124.8, 119.8, 112.3, 110.3, 108.0, 107.7, 36.7 (CH3),
36.6 (CH3), 36.1 (CH3).
3,5-Di(2,2′-bithiophen-5-yl)-1-methyl-1
H
-1,2,4-triazole (5c):
Mp 146-148 ˚C; ¹H
NMR (CDCl3): δ = 7.61 (d, J = 3.8 Hz,
1 H, H-3′′), 7.45 (d, J = 3.8
Hz, 1 H, H-3), 7.22-7.31 (m, 5 H, H-4,
H-3′, H-5′, H-3′′′,
H-5′′′), 7.17 (d, J = 3.8
Hz, 1 H, H-4′′), 7.07 (dd, J = 4.9, 3.8
Hz, 1 H), 7.03 (t, J = 4.3
Hz, 1 H, H-4′ and H-4′′′); ¹³C
NMR (CDCl3): δ = 156.9, 149.7, 140.8,
138.2, 137.2, 136.1, 131.9, 129.0, 128.1, 127.9, 127.2, 126.9, 125.6,
124.8, 124.7, 124.2, 124.1, 124.0, 37.3 (CH3).
<A NAME="RD27809ST-20">20</A>
General Procedure:
A mixture of 5-monosubstituted triazole 4 (1
equiv), stannyl derivative (2; 1.3 equiv),
PdCl2 (PPh3)2 (0.02
equiv) and LiCl (3 equiv) or CuI (0.1 equiv) was irradiated at the
appropriate temperature and for the appropriate time under argon
in a Discover™ (CEM) focused microwave reactor. The crude
products 6a-c were purified
by flash chromatography on silica gel (hexane-EtOAc).
1-Methyl-3-(1-methyl-1
H
-pyrrol-2-yl)-5-(thiophen-2-yl)-1
H
-1,2,4-triazole
(6a): Mp 88-89 ˚C; ¹H
NMR (CDCl3): δ = 7.53 (dd, J = 3.7, 1.5
Hz, 1 H, H-3′′), 7.52 (dd, J = 5.1, 1.1
Hz, 1 H, H-5′′), 7.18 (dd, J = 5.1, 3.7
Hz, 1 H, H-4′′), 6.81 (dd, J = 3.7, 1.8
Hz, 1 H, H-5′), 6.70 (t, J = 2.2
Hz, 1 H, H-3′), 6.17 (dd, J = 3.7,
2.6 Hz, 1 H, H-4′), 4.08 (s, 3 H, CH3),
4.00 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 156.3, 149.1, 129.5,
128.5, 128.2, 127.8, 125.2, 124.4, 110.8, 107.8, 37.0 (CH3),
36.5 (CH3).
3-(2,2′-Bithiophen-5-yl)-1-methyl-5-(thiophen-2-yl)-1
H
-1,2,4-triazole
(6b): Mp 124-126 ˚C; ¹H
NMR (CDCl3): δ = 7.62 (d, J = 3.8 Hz,
1 H, H-4′′), 7.57 (dd, J = 3.7,
1.1 Hz, 1 H, H-3′′′), 7.55 (dd, J = 5.1, 1.1
Hz, 1 H, H-5′′′), 7.24-7.23 (m,
2 H, H-3′, H-5′), 7.20 (dd, J = 5.1, 3.7
Hz, 1 H, H-4′′′), 7.07 (dd, J = 3.8 Hz,
1 H, H-3′′), 7.03 (dd, J = 3.8,
4.9 Hz, 1 H, H-4′), 4.09 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 156.9, 150.1, 138.2,
137.2, 131.9, 128.9, 128.8, 128.7, 127.9, 126.9, 124.7, 124.4, 124.0,
37.2 (CH3).
2-[1-Methyl-3-(thiophen-2-yl)-1
H
-1,2,4-triazol-5-yl]pyrazine
(6c): Mp 139-140 ˚C; ¹H
NMR (CDCl3): δ = 9.55 (d, J = 1.7 Hz,
1 H, H-3 Py), 8.64-8.67 (m, 2 H, H-5, H-6
Py), 7.75 (dd, J = 3.7,
1.1 Hz, H-3 thioph), 7.37 (dd, J = 5.1,
1.1 Hz, 1 H, H-5 thioph), 7.13 (dd, J = 5.1,
3.7 Hz, 1 H, H-4 thioph), 4.37 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 157.5, 150.1, 145.4,
144.7, 143.5, 143.0, 133.5, 127.7, 126.5, 126.3.
<A NAME="RD27809ST-21">21</A>
General Procedure:
A mixture of 1-phenyl-4-(tributyl-stannyl)-1H-1,2,3-triazole
(11; 100 mg, 0.23 mmol), halogenated derivative 12 (0.25 mmol), PdCl2(PPh3)2 (3
mg, 0.004 mmol) and LiCl (29.3 mg, 0.69 mmol) was irradiated at
the appropriate temperature and for the appropriate time under argon
in a Discover™ (CEM) focused microwave reactor. The crude
products 13a-g were
purified by flash chromatography (hexane-EtOAc).
4-(3,5-Dimethylphenyl)-1-phenyl-1
H
-1,2,3-triazole (13a):
Mp 115-116 ˚C; ¹H
NMR (CDCl3): δ = 8.1 (s, 1 H, H-5),
7.8 (d, J = 7.3
Hz, 2 H, o-PhH), 7.5 (m, 4 H,
Ph′H), 7.4 (t, J = 7.3
Hz, 1 H, p-Ph′H), 7.0
(s, 1 H, p-PhH), 2.2 (s, 6 H, 2 × CH3); ¹³C
NMR (CDCl3): δ = 148.6, 138.5, 137.1,
130.1, 129.9, 128.7, 123.6, 120.5, 117.5, 21.3 (CH3).
4-(2,6-Dimethylphenyl)-1-phenyl-1
H
-1,2,3-triazole (13b):
Colorless oil; ¹H NMR (CDCl3): δ = 7.9
(s, 1 H, H-5), 7.8 (d, J = 7.1
Hz, 2 H, o-PhH), 7.5 (t, J = 6.9 Hz,
2 H,
m-PhH), 7.4 (t, J = 7.3 Hz,
1 H, p-PhH), 7.2-7.1
(m, 3 H, PhH′), 2.3 (s, 6 H, 2 × CH3); ¹³C
NMR (CDCl3): δ = 146.2, 137.9, 137.1,
129.8, 129.6, 123.6, 120.3, 117.5, 20.8 (CH3).
4-(3-Bromophenyl)-1-phenyl-1
H
-1,2,3-triazole
(13c): Yellow oil; ¹H NMR (CDCl3): δ = 8.2
(s, 1 H), 8.0 (m, 1 H), 7.8-7.7 (m, 3 H),
7.6-7.5 (m, 4 H), 7.3 (t, J = 7.3
Hz, 1 H, p-PhH); ¹³C
NMR (CDCl3): δ = 147.0, 136.9, 132.3,
131.3, 130.5, 129.8, 128.9, 128.8, 124.4, 123.0, 120.6, 117.9.
4-(Naphthalen-1-yl)-1-phenyl-1
H
-1,2,3-triazole
(13d): Mp 106-107 ˚C; ¹H
NMR (CDCl3): δ = 8.5-8.4 (m,
1 H, H-Naph), 8.2 (s, 1 H, H-5), 7.9-7.8
(m, 5 H), 7.6-7.4 (m, 6 H); ¹³C
NMR (CDCl3): δ = 147.6, 137.1, 133.9,
131.2, 129.9, 129.8, 129.2, 128.8, 128.5, 127.7, 127.4, 126.7, 126.1, 125.4,
120.6.
2-(1-Phenyl-1
H
-1,2,3-triazol-4-yl)pyrazine
(13e): Colorless oil; ¹H NMR (CDCl3): δ = 9.5
(s, 1 H, H-Py), 8.6 (s, 1 H, H-5), 8.6-8.5
(m, 2 H, H-Py), 7.8 (d, J = 7.3
Hz, 2 H, o-PhH), 7.5 (t, J = 7.3 Hz,
2 H, m-PhH), 7.4 (t, J = 7.3 Hz, 1 H, p-PhH); ¹³C
NMR (CDCl3): δ = 146.6, 145.7, 144.1, 143.9,
142.3, 136.7, 129.9, 129.2, 120.9, 120.6.
1,1′-Diphenyl-1
H
,1′
H
-4,4′-bi(1,2,3-triazole)
(13f): Mp 118-119 ˚C; ¹H
NMR (CDCl3): δ = 8.6 (s, 1 H),
8.0 (s, 1 H), 7.7 (d, J = 7.3
Hz, 4 H, o-PhH), 7.5 (t, J = 7.3 Hz,
4 H,
m-PhH), 7.4 (d, J = 7.3 Hz,
2 H, p-PhH). ¹³C
NMR (CDCl3): δ = 137.0, 134.4, 129.7,
128.7, 121.6, 120.6.
4-(3-Bromo-1-methyl-1
H
-1,2,4-triazol-5-yl)-1-phenyl-1
H
-1,2,3-triazole
(13g): Mp 104-105 ˚C; ¹H
NMR (CDCl3): δ = 8.5 (s, 1 H,
H-5), 7.7 (d, J = 7.3
Hz, 2 H,
o-PhH), 7.5
(t, J = 8
Hz, 2 H, m-PhH), 7.4 (d, J = 7.1 Hz, 1 H, p-PhH), 4.3 (s, 3 H, CH3); ¹³C
NMR (CDCl3): δ = 147.5, 138.9, 137.7,
136.3, 130.1, 129.6, 122.6, 120.6, 38.3 (CH3).